iSpeak Blog

Enhancing Pharmaceutical Quality Through AI

Giulia Dini
Yvonne Burazer
AI-Image by Aristal Branson from Pixabay

Pharmaceutical manufacturing faces mounting pressure to comply with stringent regulatory requirements while maintaining the highest standards of quality, speed, and efficiency. As digital transformation revolutionizes industries, artificial intelligence (AI) is emerging as a critical driver of change in reshaping how pharmaceutical companies operate. This article continues our exploration of AI’s growing impact on pharmaceutical manufacturing, focusing on AI’s key role in improving quality at critical stages, from raw material intake to predictive maintenance.

Strengthening the Foundation: AI at the Material Intake Stage

Quality assurance in pharmaceutical manufacturing doesn’t begin in the lab or on the production line, it starts at the material intake stage. Verifying the quality of raw materials is essential for preventing downstream production issues and ensuring product integrity. AI-driven technologies can enhance supplier oversight by using machine learning (ML) algorithms to assess raw material quality and predict supplier performance.

AI applications, like real-time material tracking and predictive analytics, can drastically reduce risks posed by variations in raw materials. In one real-world example, AI was used to analyze large volumes of historical supplier data and detect patterns in material quality. By predicting when raw materials might fall short of quality expectations, companies can take proactive measures, minimizing delays and maintaining consistent product standards.


Operationalig AI: Key Functions and Their Impact
FunctionAI Contribution
Data IngestionHistorical process data (speed, temperature, duration), product yield, impurity profiles
Modeling and Pattern DetectionML identifies parameter combinations that correlate with optimal outcomes
Real-Time MonitoringAI monitors critical process parameters to ensure manufacturing within defined ranges
Dynamic AdjustmentProcess parameters adjusted proactively to stay within defined optimal operating space

Visual Inspection: Accelerating Quality Control with AI

Another key area where AI is improving quality control is visual inspection. Traditionally, visual inspection was a labor-intensive process with a high risk of human error. AI technologies, including computer vision, are now being deployed to automate visual inspections, providing faster and more accurate results.

AI-powered systems can instantly identify defects in materials or products, such as cracks, discoloration, or inconsistencies, which might otherwise go unnoticed. These systems learn from vast datasets of images to continuously improve their accuracy, ensuring that inspections are consistent, reliable, and traceable. By integrating these technologies, companies can reduce the risk of contamination, rework, and costly recalls, leading to more efficient manufacturing processes.

Right-First-Time Active Pharmaceutical Ingredients (API) Manufacturing

One of the most significant benefits of AI in pharmaceutical manufacturing is the ability to optimize processes, particularly in the production of APIs. AI has been proven to improve the efficiency of API manufacturing by predicting the ideal process conditions and monitoring real-time data to maintain consistency.

A prominent example of this is the granulation process, where AI helps to predict the optimal moisture content for granules, reducing the chances of batch failure. In a case study, an AI system monitored critical process parameters during granulation, enabling operators to adjust conditions in real-time. As a result, the production cycle was shortened, and product quality was significantly improved, with fewer deviations and quicker batch releases.


Critical Enablers for Successful AI-Driven Process Optimization in Pharma
RequirementDescription
Extensive product knowledgeHistorical data on product behavior under diverse conditions, spanning multiple batches or campaigns
Comprehensive Process UnderstandingData on critical process parameters, deviation patterns, and historical root causes
Design Space DevelopmentAccurate sensors, consistent maintenance logs, and performance traceability
Reliable EquipmentReal-time monitoring, control loop optimization, adaptive thresholds
Context-Specific AI ModelsTailored per product group or platform; generalized models often fall short in regulated environments

AI’s Role in Emerging Modalities like Advanced Therapy Medicinal Products (ATMPs)

As pharmaceutical manufacturing evolves, AI is also proving essential in supporting the production of ATMPs, which often involve complex, small-batch processes. According to ISPE, AI’s ability to handle high variability and limited data makes it especially well-suited to the needs of ATMP manufacturing, where flexibility, speed, and precision are critical.

Batch Comparison: Ensuring Consistency Across Batches

AI’s role in batch comparison is another area where its impact is making waves. Traditional batch comparisons were often done manually, leading to delays and inconsistencies in the final product. AI-powered batch comparison tools now enable manufacturers to compare batches quickly and accurately by analyzing process data from different production runs.

These systems can detect subtle deviations between batches that may not be immediately visible, allowing for earlier interventions before quality is compromised. This capability is particularly useful in regulated environments where batch consistency is critical for compliance. By automating batch comparison, companies can ensure that every batch meets the same high standards, ultimately reducing variability and improving overall product quality.


Figure 1: AI-powered batch comparison of temperature profiles during a critical process phase.

The green lines represent temperature traces from new campaign batches, while the blue lines show historical low-yield batches. The shaded area indicates the target profile range. AI detects deviations such as (1) early temperature rise and (2) transient overshoot, which are potential indicators of batch performance issues. This automated comparison enables earlier interventions, improved consistency, and enhanced quality oversight.

Source: Case study from a global contract development manufacturing organization (CDMO) 


Predictive Maintenance: Preventing Equipment Failures Before They Happen

Predictive maintenance is another area where AI is transforming pharmaceutical manufacturing. With AI-powered systems, equipment failures can be predicted and prevented before they impact production. ML algorithms analyze data from sensors embedded in equipment to predict potential breakdowns or performance declines.

For example, AI systems can monitor the condition of critical equipment like centrifuges or compressors, analyzing vibrations, temperature fluctuations, and other performance indicators to identify early warning signs of wear. This allows operators to take corrective action before a failure occurs, minimizing downtime and reducing maintenance costs. In a recent case, AI-driven predictive maintenance helped a pharmaceutical manufacturer avoid unexpected machine failures, saving significant costs and maintaining continuous production.


Figure 2

Early warning detection through correlated process signals and alarm history. By analyzing trends in process flow and penicillin concentration alongside alarm logs, AI can detect patterns that precede equipment failure. This enables predictive maintenance strategies that reduce unplanned downtime and extend asset life.

Source: Bioprocessing dataset from a large-scale CDMO implementing predictive batch analytics. 


AI in Ongoing Monitoring: Visual Key Performance Indicators (KPIs) for Continuous Quality Assurance

AI-driven visual dashboards are helping to continuously monitor KPIs in real time. These dashboards display essential data such as production speed, yield, and downtime, giving managers an immediate snapshot of operations. AI enhances these dashboards by analyzing historical and real-time data to highlight trends and predict future outcomes.

For example, an AI-powered KPI dashboard might display the correlation between certain process variables and yield rates, helping operators adjust conditions before issues arise. The ability to proactively monitor KPIs and take immediate action helps manufacturers maintain optimal production conditions and ensure compliance with regulatory standards.


Figure 3

Real-time monitoring dashboard with AI-driven deviation alerts during fermentation. The system displays univariate control charts for pressure, temperature, and agitation, highlighting deviations from expected behavior (orange zones). Integrated alerts, including outlier detection and process control deviations, support faster decision-making and enhanced quality oversight.

Source: Real-time monitoring interface from a large-scale CDMO using predictive batch analytics in bioprocessing


Scenarios: AI in Granulation, Flow Rate, and Energy Optimization

Beyond the core use cases of quality control and maintenance, AI is also being applied in energy management and resource optimization. AI technologies are capable of analyzing large datasets from multiple sources to optimize energy consumption, flow rates, and process efficiencies.

For instance, in granulation, AI models can predict the ideal energy levels needed to achieve consistent results, preventing energy waste and improving the overall efficiency of the process. Similarly, AI-driven flow rate optimization tools can ensure that material handling systems are running at their most efficient, reducing delays and preventing bottlenecks. These technologies help pharmaceutical companies achieve more sustainable operations while also reducing production costs.


Figure  4

Principal component analysis distinguishes granulation batches by production line, revealing patterns that traditional analysis missed. AI helps uncover subtle, multivariate factors behind variability in powder flow, supporting more precise, predictive control.

Source: Multivariate analytics interface from a large-scale CDMO applying predictive control in biopharmaceutical manufacturing


AI’s Contribution to Quality, Efficiency and Compliance
Benefit AreaValue Delivered
Quality Risk MitigationLeverages digital twins to predict quality deviations before they occur; supports raw material approval decisions
Yield OptimizationPrevents poor-quality batches and reduces downstream disruptions
Waste ReductionMinimizes loss from unsuitable inputs or poorly tuned process parameters
Faster Decision-MakingEnables earlier, data-supported go/no-go decisions at material acceptance or release
Integration with QMS/QbDSupports Quality by Design (QbD) principles and traceability in Quality Management Systems (QMS)

Regulatory Readiness: Encouraging Industry Momentum

While pharmaceutical companies advance their AI capabilities, it’s important to recognize that regulators are also preparing for and supporting this shift. As highlighted by ISPE, regulatory bodies are actively measuring and encouraging the industry’s adoption of Pharma 4.0 principles, including AI and advanced analytics, as a way to strengthen quality and compliance frameworks.


AI Impact Across Key Stakeholders
StakeholderAI Impact
Quality AssuranceAutomates verification, enables faster decision-making, reduces cognitive load
Qualified PersonSupports rapid assessment of batch readiness and exception handling
Production ManagersMinimizes downtime and supports schedule adherence via predictive insights
Regulatory OfficersEnhances compliance documentation and simplifies audit prep
Finance LeadersLowers costs and reduces risk of product recalls or noncompliance penalties

Conclusion: AI's Transformative Role in Pharmaceutical Quality

As the use cases discussed here show, AI is poised to redefine pharmaceutical manufacturing by strengthening quality at every stage, from material intake to equipment maintenance. And of course, AI technologies are in continuous evolution, which means it’s safe to say their role in pharmaceutical manufacturing will only expand. By starting to embrace these technologies, pharmaceutical manufacturers can drive improvements in quality assurance, operational efficiency, and compliance, achieving more consistent, reliable, and faster production processes while reducing costs and enhancing patient safety.1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11

Articles in This Series

ISPE members: View ISPE Communities of Practice. 
Not an ISPE member? Join today.

Disclaimer

iSpeak Blog posts provide an opportunity for the dissemination of ideas and opinions on topics impacting the pharmaceutical industry. Ideas and opinions expressed in iSpeak Blog posts are those of the author(s) and publication thereof does not imply endorsement by ISPE.


Submit Your Best Content to ISPE

ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.  

What We Look For 

References